NCT05984095 is a NA clinical trial of Telerehabilitation in Multiple Sclerosis, sponsored by University of Trieste.

Who is sponsoring NCT05984095?

NCT05984095 is sponsored by University of Trieste.

What drugs are being tested in NCT05984095?

Interventions in NCT05984095: Telerehabilitation.

What condition does NCT05984095 study?

NCT05984095 studies Multiple Sclerosis.

Is NCT05984095 still recruiting?

NCT05984095 is currently completed. Last updated 28 November 2023.

Last reviewed 2023-11-28 · How we verify

NCT05984095

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multiple Sclerosis Pelvic Floor Telerehabilitation

Completed NA Last updated 28 November 2023

What this trial tests

NA trial testing Telerehabilitation in Multiple Sclerosis in 28 participants. Completed in 25 November 2023.

Timeline

15 September 2023

Primary endpoint
15 November 2023

25 November 2023

Quick facts

Lead sponsor	University of Trieste
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	28
Start date	15 September 2023
Primary completion	15 November 2023
Estimated completion	25 November 2023
Sites	1 location across Italy

Drugs / interventions tested

Telerehabilitation

Conditions studied

Multiple Sclerosis — all drugs for Multiple Sclerosis →

Sponsor

University of Trieste

Who can join

Adults 18 to 50, female only, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to compare the effects of two different pelvic floor telerehabilitation protocols on selected measures of quality of life and health in females with relapsing-remitting Multiple Sclerosis (rrMS). The main questions it aims to answer are: * Is telerehabilitation sufficient to improve quality of life and health in females with rrMS, in particular dedicated to pelvic floor training? * Are self-administered training protocols or remotely-supervised training protocols equally effective? Participants will be randomized to two intervention groups: a self-administered training protocol (SELF) and a remotely-supervised (REMOTE) training protocol. Both protocols will consist in 10 sessions of pelvic floor training lasting 45 min each, once every 5 days. At the start and at the end of the protocol, all participants will complete 6 questionnaires regarding pain, quality of life and health.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Comparison of different telerehabilitation protocols for urogenital symptoms in females with multiple sclerosis: a randomized controlled trial.
Deodato M, Fornasaro M, Martini M, Zelesnich F, et al · · 2024 · cited 1× · PMID 39223424 · DOI 10.1007/s10072-024-07742-y

Verify or expand the search:

Other trials of Telerehabilitation

Trials testing the same drug.

NCT07327008 — The Effectiveness of Telerehabilitation in Liver Transplant Patients · NA · not yet recruiting
NCT07310914 — Implementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis · Phase 2 · not yet recruiting
NCT07302386 — Exercise Management in Parkinson's Disease · NA · recruiting
NCT06984380 — Tele-Rehabilitation Intervention in Community-Based Healthcare for Patients With Osteoporosis (DHEAL-COM-OP) · NA · not yet recruiting
NCT06871072 — Telerehabilitation for Multiple Sclerosis · NA · completed

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

NCT07507084 — The Effect of Internal- or External-Focused Exercise Training, Administered in Conjunction With a Cognitive Task, on Wal · NA · recruiting
NCT07524231 — Evaluation of the Effects of Laughter Yoga · NA · recruiting
NCT07489794 — URINARY INCONTINENCE AND PELVIC FLOOR MUSCLE ACTIVITY IN MULTIPLE SCLEROSIS · recruiting
NCT07236684 — Identification of Factors Related to UI in Patients With MS and EMG Assessment of PFM Activity · recruiting
NCT07500727 — Skeletal Muscle Aging and Responsiveness in Aged People With MS · NA · recruiting

Other University of Trieste trials

Trials by the same sponsor.

NCT07430046 — Repurposing Mirtazapine in Rett Syndrome · Phase 2 · recruiting
NCT07006571 — At-home Treatment With Cortico-spinal tDCS for Amyotrophic Lateral Sclerosis · NA · recruiting
NCT06331416 — Multiparametric Home Telemonitoring of Patients With Chronic Obstructive Pulmonary Disease Exacerbation · NA · recruiting
NCT06433856 — Neuromuscular Responses to Recovery Techniques · NA · completed
NCT05596058 — Non-pharmacological Treatments in Migraine. · NA · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05984095 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Trieste
Last refreshed: 28 November 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05984095.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing